Computational Intelligence (CI) Tools in Drug Discovery and Design

Dear Colleagues,

The demand of new drugs has increased in the last decades. Therefore, the discovery and development of new drugs and their pharmaceutical forms need to be fast and efficient, while maintaining a high quality. This may require the use of computational intelligence (CI) tools. CI usually refers to a program which is able to solve complex problems without prior knowledge of a phenomenon, by learning from data or experimental observations. Computers currently surpass the human brain in terms of data processing, and, if properly designed, computer programs could significantly accelerate the development of new drugs. Moreover, CI tools could help to discover complex and sometimes unobvious interactions between drugs and biological targets.

The purpose of this Special Issue of Pharmaceutics is to gather novel and interesting scientific research regarding the applications of computational intelligence tools in drug discovery and development. The focus will be on research articles and reviews on drug dosage forms and novel substances whose development was motivated by computational intelligence tools. Studies on other technological and pharmaceutical aspects of computer-aided drug design will also be welcome.

Dr. Jakub Szlęk
Dr. Adam Pacławski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.